Biden cancer prognosis is serious, but could benefit from precision med advances he’s championed

Biden cancer prognosis is serious, but could benefit from precision med advances he’s championed

Nearly a decade since launching his Cancer Moonshot, the oncology research and precision medicine innovations of that project, along with other NIH-funded health data initiatives, have enabled advancements in personalized treatment and management.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *